PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 19, 2026The Journal of Clinical Endocrinology & Metabolism0 citations

Insights from changes in NDEV biomarkers of metabolism: Effects of PPARγ and GLP1 receptor agonists on brain metabolism

View Full Paper
AEAudrey EversKWKathleen WatsonFAFahim Abbasi

Key Points

  • The aim is to explore how PPARγ and GLP1 receptor agonists affect CNS-specific biomarkers related to metabolism.
  • Assessment of biomarker responses in the central nervous system (CNS)
  • Intervention with PPARγ agonists and GLP1 receptor agonists
  • Analysis of changes in brain metabolism indicators
  • Identification of CNS-specific responses to PPARγ agonists
  • Detection of significant changes in biomarkers due to GLP1 receptor agonists
  • Highlights metabolic alterations in the brain influenced by these agonists

Abstract

Our findings demonstrate CNS-specific biomarker responses to both PPARγ agonists and GLP1 receptor agonists.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Evers et al. (2026) studied this question.

synapsesocial.com/papers/69e473bd010ef96374d8f840https://doi.org/10.1210/clinem/dgag176
Ask AI
Helpful
Bookmark
Share
View Full Paper